Jefferies Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Buy
+1,578
New +$237K ﹤0.01% 1427
2026
Q1
– Sell
-4,606
Closed -$635K – 2075
2025
Q4
$635K Buy
+4,606
New +$603K ﹤0.01% 1258
2024
Q1
– Sell
-49,437
Closed -$4.99M – 1895
2023
Q4
$4.99M Buy
+49,437
New +$4.77M 0.03% 406

Other funds holding NVS

Jefferies Financial Group's NVS Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in Novartis (NVS) in Q2 2026: 1,578 shares worth $247K. The stake represents ﹤0.01% of the portfolio and ranks #1427 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in NVS as recently as Q4 2025.

Jefferies Financial Group first reported a position in NVS in Q4 2023 and has held it in 3 quarters since. The position peaked at $4.99M in Q4 2023. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Jefferies Financial Group held 1,578 shares of Novartis worth $247K as of Q2 2026.
  • Novartis was a new Jefferies Financial Group position in Q2 2026.
  • Novartis made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1427 holding.
  • Jefferies Financial Group first reported a position in Novartis in Q4 2023 and has held it in 3 quarters since.
  • Jefferies Financial Group's Novartis position peaked at $4.99M in Q4 2023.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.